As oncology is the first used in HCS, Perkin Elmer has developped new High Content Analysis Platform dedicted for Cancer Applications as you can see below:
Nathalie and Elodie will be present in Marseille for BioFit event next week! Indeed, HCS Pharma has a booth in Clubster NSL’s pavilion (number I20). Just stop by 🙂 It will be a pleasure to Read more…
If you work in 3D cell culture, you should know our innovative technology BIOMIMESYS® just recognized as a Deep Tech Pionner by Hello Tomorrow. We have more and more practical examples of uses by our Read more…
Among more than 5,000 applicants from 128 different countries, HCS Pharma has been selected by Hello Tomorrow as one of “Deep Tech Pioneers” from their annual Global Challenge 2020 with our groundbreaking technology BIOMIMESYS®! BIOMIMESYS® Read more…
0 Comments